CJC-1295 + Ipamorelin or Tesamorelin: Comparing GHRH Analogs in Research
Share
Two families of compounds dominate research on the somatotropic axis: GHRH/GHRP combinations like CJC-1295 + Ipamorelin, and pure GHRH analogs like Tesamorelin. Although they target the same hormonal axis, their research profile differs significantly.
Two distinct mechanisms
Tesamorelin is a direct GHRH analog: it binds to the GHRH receptor and stimulates a single signaling pathway. CJC-1295 + Ipamorelin combines a long-acting GHRH analog (without DAC) with a ghrelin secretagogue peptide acting on a distinct receptor (GHS-R). This dual activation is studied for a potentially more pronounced effect on GH pulsatility.
What the research literature distinguishes
- Tesamorelin: most published data concerns its interaction with visceral adipose tissue and metabolic models.
- CJC-1295 + Ipamorelin: more studied for GH secretion pulsatility, downstream IGF-1 signaling, and tissue recovery models.
- Both are studied for relative selectivity on the GH axis, with literature suggesting limited impact on cortisol and prolactin compared to older secretagogues.
How researchers choose
The choice between the two depends above all on the research question being asked: protocols focused on body composition and adipose tissue have historically relied on Tesamorelin, while protocols focused on GH pulsatility and recovery often favor the CJC-1295 + Ipamorelin combination. Both require identical storage and reconstitution (lyophilized powder, storage at 2–8°C after reconstitution).
Purity & quality standards
CELLOVATE applies the same internal standards to both compounds:
- High-purity peptide structure (≥99% HPLC)
- Testing and verification by our in-house laboratory
- Batch-to-batch consistency
- Lyophilized form, nitrogen-sealed for stability
Research use only
CJC-1295 + Ipamorelin and Tesamorelin are offered strictly as research reagents for in-vitro and laboratory studies conducted by qualified professionals. They are not drugs, supplements, or cosmetics, and are not intended for human or animal use.
View CJC-1295 + Ipamorelin on Cellovate →
View Tesamorelin on Cellovate →